[Inhibitors affecting synthesis and intracellular translocation of glycoproteins as probes].
Takatsuki
A
A
Tamura
G
G
D017485:1-Deoxynojirimycin; D015250:Aclarubicin / Q000031:analogs & derivatives*; D000818:Animals; D018943:Anthracyclines; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000903:Antibiotics, Antineoplastic; D001414:Bacitracin / Q000494:pharmacology; D001692:Biological Transport; D005944:Glucosamine / Q000031:analogs & derivatives / Q000494:pharmacology; D006023:Glycoproteins / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D055666:Lipopeptides; D008247:Lysosomes / Q000378:metabolism; D008985:Monensin / Q000494:pharmacology; D009279:Naphthacenes / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology; D012787:Showdomycin / Q000494:pharmacology; D014415:Tunicamycin / Q000032:analysis / Q000494:pharmacology
D018943:Anthracyclines; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D006023:Glycoproteins; D055666:Lipopeptides; D009279:Naphthacenes; D009842:Oligopeptides; C011157:aclacinomycins; D014415:Tunicamycin; D001414:Bacitracin; D017485:1-Deoxynojirimycin; C015338:marcellomycin; C004423:amphomycin; D015250:Aclarubicin; D008985:Monensin; D012787:Showdomycin; D005944:Glucosamine